The conference call will feature key leadership figures, including President and Group Chief Executive Officer Cameron Reynolds, Group Chief Financial Officer Terig Hughes, and Group Chief Marketing and Communications Officer Louise Batchelor. The discussion aims to review major developments from the second quarter, address subsequent events, and outline upcoming strategic milestones for the epigenetics firm.
In section Releases
VolitionRx Sets Second Quarter 2026 Earnings Call
Investors will receive a comprehensive business update from VolitionRx Limited on Friday, August 14, as the company prepares to discuss its financial and operational performance for the second quarter of 2026 at 8:30 a.m. U.S. Eastern Time.
Participants may join the live session via dial-in using conference ID 13762190. Domestic callers in the U.S. and Canada can access the line at 1-877-407-9716, while U.K. participants may use the toll-free number 0 800 756 3429. International callers should utilize 1-201-493-6779. A live audio webcast will also be accessible through the company’s website, with a telephone replay available until August 28, 2026, using the same conference ID.
Comments (0)
No comments yet. Be the first!